Madrid is leading the way in preventative medicine in Spain, with nearly five million vaccines administered in the region over the past year. The announcement came during the opening of the XV edition of the Update Course on Infectious Diseases and Clinical Use of Antimicrobials (InfeclÃnico), held at the Hospital ClÃnico San Carlos.
This widespread vaccination effort was made possible by a network of over 400 immunization points throughout the region, ensuring convenient access to preventative care for all citizens. Increased vaccination rates are a key strategy for reducing the burden of infectious diseases and protecting public health.
Focus on Flu and Respiratory Illness Protection
The vaccination campaign prioritized seasonal illnesses that place the greatest strain on the hospital system. In October, the region procured 1.6 million doses of influenza vaccine to mitigate the impact of respiratory diseases during the winter months, officials said.
Yet, the most significant focus of the event was on strategies to combat the respiratory syncytial virus (RSV), a common cause of pneumonia. Officials highlighted Madrid’s pioneering role in RSV prevention, noting two key achievements:
- Protecting the Most Vulnerable: Madrid was the first region to extend RSV immunization to individuals over 60 years of age living in care facilities or with underlying health conditions.
- Significant Success in Pediatrics: Two years after becoming the first region to immunize infants under one year of age against RSV, hospitalizations for bronchiolitis have decreased by 90% in this age group.
Advancing Treatment of Infectious Diseases
The presentation of these data at InfeclÃnico was intentional. The course, now in its fifteenth year, serves as a key forum for healthcare professionals to update their knowledge in the management of infectious diseases and the clinical use of antimicrobials – critical areas for patient safety and public health.
With these figures, the Community of Madrid reaffirms its commitment to a healthcare system based on proactive prevention, demonstrating that investment in immunization not only saves lives but also frees up vital resources by preventing thousands of hospitalizations each year.
